Tag: Insurance: Medicare
Medicare May Rethink Premium Hike for Pricey Alzheimer Drug
Announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year
Seniors Report Medical Care Missed During the Pandemic
Rates of forgone medical care because of COVID-19 decreased over time; about 70 percent of forgone care due to physician-driven factors
Flu Vaccine Coverage Suboptimal for Medicare Beneficiaries
Uptake of vaccination higher among beneficiaries with versus without high-risk conditions; missed opportunities for vaccination are common
Pricey Alzheimer Drug Drives Spike in Medicare B Premium: Officials
New premium will be $170.10 a month, and the $21.60 boost is the biggest increase ever in dollar amount, but not in percentage terms
State Limits on Initial Opioid Rx Duration May Influence Prescribing
Decreases in days of opioid prescribed for initial prescriptions in Medicare beneficiaries especially pronounced among surgeons, dentists
Medicare Mulls Coverage for Controversial Drug for Alzheimer Disease
CMS says a final decision on coverage is not likely until next spring
Patients in Bind as Brain Cancer Drug Price Rises to $1,000 Per Pill
Company's decision means there is one less option in a limited number of approved chemotherapies
Low-Value Care Exposure Not Linked to Favorable Patient Ratings
For primary care professional patient panel, more low-value care not linked to more favorable ratings of health care experience
Introduction of Sepsis Performance Measure Had Little Impact
Variable impact found on changes in process measures, with no improvement in clinical outcomes
More Long-Term Dialysis Patients Aligned to ACOs
Among Medicare beneficiaries on dialysis, less spent per beneficiary-quarter for ACO-aligned versus nonaligned
